News
AZoLifeSciences on MSN3d
In Vivo Base Editing Marks New Era in Personalized Genetic MedicineIn vivo base editing enables precise, single-nucleotide changes to DNA without double-strand breaks. A recent application in ...
Even alternate versions of CRISPR, such as nickase Cas9 (nCas9) and dead Cas9 (dCas9), showed improved editing performance under autophagic conditions.
Even alternate versions of CRISPR, such as nickase Cas9 (nCas9) and dead Cas9 (dCas9), showed improved editing performance under autophagic conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback